Maravai Lifesciences Holdings, Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
MRVI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10770 Wateridge Circle Suite 200, San Diego, CA

Insiders trading volume in the past year

Maravai Lifesciences Holdings, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gtcr Investment Xi Llc Director, 10%+ Owner $1.39B -$97.6M -6.55% May 28, 2024
William E. Martin III Chief Executive Officer $4.79M Mar 17, 2025
Carl Hull Executive Chairman, Director $2.69M +$987K +57.9% Nov 11, 2024
Peter Leddy Chief Administrative Officer $1.93M Mar 17, 2025
Kevin Herde Chief Financial Officer $1.78M Mar 17, 2025
Andrew Burch Former President, Nucleic Acid Production $1.68M Jan 15, 2025
Rebecca Buzzeo Chief Commercial Officer $1.6M Mar 17, 2025
Christine Dolan Executive Vice President and General Manager, Cygnus Technologies $1.24M Mar 17, 2025
Kurt Oreshack General Counsel $1.21M -$126K -9.44% Mar 17, 2025
Jessica Hopfield Director $1.19M May 23, 2024
Susannah Gray Director $871K May 23, 2024
Murali Prahalad Director $706K May 23, 2024
Anat Ashkenazi Director $655K May 23, 2024
R. Andrew Eckert Director $594K Dec 16, 2024
Constantine S. Mihas Director $527K May 23, 2024
Benjamin Daverman Director $527K May 23, 2024
Luke Marker Director $527K May 23, 2024
Sean Laurence Cunningham Director $527K May 23, 2024
John A. DeFord Director $403K +$101K +33.3% Nov 12, 2024
Gregory T. Lucier Director $335K Dec 9, 2024
Robert B. Hance Director $136K Nov 19, 2021
Brian Neel Chief Operating Officer, Nucleic Acid Production $85.5K Feb 15, 2023

Recent Insider Transactions by Companies or Individuals for Maravai Lifesciences Holdings, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.